tiprankstipranks

Perspective Therapeutics initiated with an Overweight at Cantor Fitzgerald

Cantor Fitzgerald analyst Louise Chen initiated coverage of Perspective Therapeutics with an Overweight rating. Perspective Therapeutics has a robust pipeline with multiple near-term data readouts and is a fully integrated radiopharma company advancing potentially best- or first-in-class alpha-particle therapies, the analyst tells investors in a research note. Perspective stands out above the competition where it matters, Cantor argues, adding that positive data for VMT01 could open up a large market opportunity. The stock looks undervalued based on recent M&A activity, the firm adds.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue